The Association of the British Pharmaceutical Industry (ABPI) has warned UK lawmakers that an existing pricing agreement is unsustainable, and that the cost of 15 December 2022
The outcome of the recent mid-term elections in the USA surprised many by returning a Democrat-led Senate, preventing Republicans from gaining control of the ne 28 November 2022
Members of the World Trade Organization (WTO) are discussing expanding a waiver on Trade-Related Aspects of Intellectual Property Rights (TRIPS) to include ther 28 November 2022
A decade on from the founding of The Cell and Gene Therapy Catapult (CGT Catapult), the UK-based industry accelerator is celebrating its successes. 22 November 2022
Alnylam has announced that it will not presently be taking its drug Amvuttra (vutrisiran) into a Phase III trial for Stargardt disease. 28 October 2022
The pharmaceutical industry in Europe has questioned measures aimed at improving the way wastewater is treated by countries within the European Union. 28 October 2022
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.